This case examined Pharco Pharmaceuticals’ strategy to eliminate hepatitis C in Egypt, highlighting the intersection of strategic innovation and public health. In October 2023, chief executive officer Dr. Sherine Helmy had to chart the company’s next steps in a way that would preserve the company’s leadership position, advance its commitment to equitable health access, and navigate the volatile terrain of global health diplomacy. The case, taught through the lens of shared value creation, invited critical evaluation of how companies in emerging markets could align profit with purpose.
看看哪些人也有訂購？